2024 Trending Now in Cancer Care

Know cancer's next move with the Signatera Molecular Residual Disease AssayTumor-informed MRD testing for optimized patient management Signatera is a highly sensitive and tumor-informed molecular residual disease assay (MRD) using circulating tumor DNA (ctDNA), custom designed for each patient to help inform earlier intervention.

Authors

Institutions

Publication Details

Journal
Oncology Issues
Published
2024-10-01
DOI
https://doi.org/10.3928/25731777-20241023-01
Primary Topic
Economic and Financial Impacts of Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

2024 Trending Now in Cancer Care

Mark Liu
Oncology Issues
Economic and Financial Impacts of Cancer
article

2024 Trending Now in Cancer Care

Mark Liu
article en

Abstract

Know cancer's next move with the Signatera Molecular Residual Disease AssayTumor-informed MRD testing for optimized patient management Signatera is a highly sensitive and tumor-informed molecular residual disease assay (MRD) using circulating tumor DNA (ctDNA), custom designed for each patient to help inform earlier intervention.

Oncology IssuesVol. 39(5)
Baptist Health South Florida (US)
Openalex Percentile: Top 77%
Economic and Financial Impacts of Cancer
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

2024 Trending Now in Cancer Care — Mark Liu · Oncology Issues (2024) | TGRS Research Map | TGRS